AKT1 and hepatocellular carcinoma: The mammalian target of rapamycin (mTOR) is aberrantly phosphorylated and activated by PI3K-AKT signaling in many human malignancies, including HCC, and plays a critical role in HCC oncogenesis [19, 33, 34].